Constance McKee
Co-Executive Director, Americans for Cures Foundation

Constance McKee has a background in for-profit biotechnology companies and not-for-profit bioentrepreneurship.

Constance's accomplishments include:

• Founder and CEO of Manzanita Pharmaceuticals, Inc., an emerging biotechnology company developing a novel product for treating pain
• Chief Executive of Cambridge Quantum Fund I, the original seed fund investing in Cambridge University technologies (Cambridge, UK - 1990-1994)
• Co-founder and Board Member of the Bay Area's non-profit seminar program for bioentrepreneurs, BioE2E.org
• Founder of a non-credit course at Yale University called "Business of Biotech" for Yale life sciences students and faculty

Constance earned her BA at Stanford University (with honors) and her MBA from Yale University. In 1985-1986 she was a recipient of a fellowship from the Robert Bosch Foundation which supported internships in corporate finance in Germany.